These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 6126744)

  • 1. Ketoconazole, cyclosporin metabolism, and renal transplantation.
    Ferguson RM; Sutherland DE; Simmons RL; Najarian JS
    Lancet; 1982 Oct; 2(8303):882-3. PubMed ID: 6126744
    [No Abstract]   [Full Text] [Related]  

  • 2. Combining cytochrome P-450 3A4 modulators and cyclosporine or everolimus in transplantation is successful.
    González F; Valjalo R
    World J Transplant; 2015 Dec; 5(4):338-47. PubMed ID: 26722662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of the antifungal agents on oxidative drug metabolism: clinical relevance.
    Venkatakrishnan K; von Moltke LL; Greenblatt DJ
    Clin Pharmacokinet; 2000 Feb; 38(2):111-80. PubMed ID: 10709776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The clinical and economic potential of cyclosporin drug interactions.
    Martin JE; Daoud AJ; Schroeder TJ; First MR
    Pharmacoeconomics; 1999 Apr; 15(4):317-37. PubMed ID: 10537952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of other drugs to allow a lower dosage of cyclosporin to be used. Therapeutic and pharmacoeconomic considerations.
    Jones TE
    Clin Pharmacokinet; 1997 May; 32(5):357-67. PubMed ID: 9160170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinically significant drug interactions with cyclosporin. An update.
    Campana C; Regazzi MB; Buggia I; Molinaro M
    Clin Pharmacokinet; 1996 Feb; 30(2):141-79. PubMed ID: 8906896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary care of the renal transplant patient.
    Pirsch JD; Friedman R
    J Gen Intern Med; 1994 Jan; 9(1):29-37. PubMed ID: 8133348
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmacokinetic drug interactions with antimicrobial agents.
    Gillum JG; Israel DS; Polk RE
    Clin Pharmacokinet; 1993 Dec; 25(6):450-82. PubMed ID: 8119047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluconazole is removed by continuous venovenous hemofiltration in a liver transplant patient.
    Scholz J; Schulz M; Steinfath M; Höver S; Bause H
    J Mol Med (Berl); 1995 Mar; 73(3):145-7. PubMed ID: 7633952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclosporine: immunology, toxicity and pharmacology in experimental animals.
    Thomson AW; Whiting PH; Simpson JG
    Agents Actions; 1984 Oct; 15(3-4):306-27. PubMed ID: 6395677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclosporin A: pharmacologic activity on the immune system and effects in clinical organ transplantation.
    Block LH; Sutter PM; Mihatsch MJ
    Klin Wochenschr; 1983 Nov; 61(21):1053-62. PubMed ID: 6358655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunosuppressive activity and toxicity of cyclosporin A in rats pretreated with high dose cyclophosphamide.
    Brown PA; Thomson AW; Whiting PH; Davidson RJ; Simpson JG
    Agents Actions; 1985 Oct; 17(1):67-72. PubMed ID: 4083181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extraction ratio of cyclosporine in a liver transplant patient with organ rejection.
    Venkataramanan R; Ptachcinski RJ; Burckart GJ; Yang S; Starzl TE
    J Pharm Sci; 1985 Aug; 74(8):901-2. PubMed ID: 3897511
    [No Abstract]   [Full Text] [Related]  

  • 14. Cyclosporine trough concentration monitoring in liver transplant patients.
    Burckart GJ; Ptachcinski RJ; Venkataramanan R; Iwatsuki S; Esquivel C; Van Thiel DH; Starzl TE
    Transplant Proc; 1986 Dec; 18(6 Suppl 5):188-93. PubMed ID: 3538569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclosporine pharmacokinetic profiles in liver, heart, and kidney transplant patients as determined by high-performance liquid chromatography.
    Burckart GJ; Venkataramanan R; Ptachcinski RJ; Starzl TE; Griffith BP; Hakala TR; Rosenthal JT; Hardesty RL; Iwatsuki S; Brady J
    Transplant Proc; 1986 Dec; 18(6 Suppl 5):129-36. PubMed ID: 3538565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction between cyclosporin A and phenobarbitone.
    Carstensen H; Jacobsen N; Dieperink H
    Br J Clin Pharmacol; 1986 May; 21(5):550-1. PubMed ID: 3521692
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical pharmacokinetics of cyclosporin.
    Ptachcinski RJ; Venkataramanan R; Burckart GJ
    Clin Pharmacokinet; 1986; 11(2):107-32. PubMed ID: 3514043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical pharmacokinetics of ketoconazole.
    Daneshmend TK; Warnock DW
    Clin Pharmacokinet; 1988 Jan; 14(1):13-34. PubMed ID: 3280211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug interactions that matter. A critical reappraisal.
    McInnes GT; Brodie MJ
    Drugs; 1988 Jul; 36(1):83-110. PubMed ID: 3063497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of systemic fungal infections: recent progress and current problems.
    Walsh TJ; Pizzo A
    Eur J Clin Microbiol Infect Dis; 1988 Aug; 7(4):460-75. PubMed ID: 2846299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.